1-9 of 9
Christoph C. Zielinski
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase II Trial of HER-Vaxx, a B-cell Peptide-Based Vaccine, in HER2-Overexpressing Advanced Gastric Cancer Patients Under Platinum-Based Chemotherapy (HERIZON)

Joshua Tobias, Marina Maglakelidze, Zoran Andrić, Dinara Ryspayeva, Iurie Bulat, Ivan Nikolić, Zoran Petrović, Tanuj Chawla, Rajnish Nagarkar, Erika Garner-Spitzer, Christoph C. Zielinski, Leslie Mi Ok Chong, Bonnie Nixon, Nicholas J. Ede, Sharon Yavrom, Michael Kundi, Ursula Wiedermann
Journal: Clinical Cancer Research
Clin Cancer Res (2024) 30 (18): 4044–4054.
https://doi.org/10.1158/1078-0432.CCR-24-0742
Published: 13 September 2024
View articletitled, Phase II Trial of HER-Vaxx, a B-cell Peptide-Based Vaccine, in HER2-Overexpressing Advanced Gastric Cancer Patients Under Platinum-Based Chemotherapy (HERIZON)
Open the PDF for Phase II Trial of HER-Vaxx, a B-cell Peptide-Based Vaccine, in HER2-Overexpressing Advanced Gastric Cancer Patients Under Platinum-Based Chemotherapy (HERIZON) in another window
Includes: Supplementary data
Journal Articles

Clinical and Immunologic Responses to a B-Cell Epitope Vaccine in Patients with HER2/neu-Overexpressing Advanced Gastric Cancer—Results from Phase Ib Trial IMU.ACS.001

Ursula Wiedermann, Erika Garner-Spitzer, Yee Chao, Marina Maglakelidze, Iurie Bulat, Arunee Dechaphunkul, Wichit Arpornwirat, Chaiyut Charoentum, Chia-Jui Yen, Thomas Cheung Yau, Suebpong Tanasanvimon, Jedzada Maneechavakajorn, Aumkhae Sookprasert, Li-Yuan Bai, Wen-Chi Chou, Teerapat Ungtrakul, Mirjana Drinic, Joshua Tobias, Christoph C. Zielinski, Leslie Chong, Nicholas J. Ede, Mark T. Marino, Anthony J. Good
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2021) 27 (13): 3649–3660.
https://doi.org/10.1158/1078-0432.CCR-20-3742
Published: 01 July 2021
View articletitled, Clinical and Immunologic Responses to a B-Cell Epitope Vaccine in Patients with HER2/neu-Overexpressing Advanced Gastric Cancer—Results from Phase Ib Trial IMU.ACS.001
Open the PDF for Clinical and Immunologic Responses to a B-Cell Epitope Vaccine in Patients with HER2/neu-Overexpressing Advanced Gastric Cancer—Results from Phase Ib Trial IMU.ACS.001 in another window
Includes: Supplementary data
Journal Articles

Continued Endocrine Therapy Is Associated with Improved Survival in Patients with Breast Cancer Brain Metastases

Elisabeth S. Bergen, Anna S. Berghoff, Mela Medjedovic, Margaretha Rudas, Florian Fitzal, Zsuzsanna Bago-Horvath, Karin Dieckmann, Robert M. Mader, Ruth Exner, Michael Gnant, Christoph C. Zielinski, Guenther G. Steger, Matthias Preusser, Rupert Bartsch
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (9): 2737–2744.
https://doi.org/10.1158/1078-0432.CCR-18-1968
Published: 01 May 2019
View articletitled, Continued Endocrine Therapy Is Associated with Improved Survival in Patients with Breast Cancer Brain Metastases
Open the PDF for Continued Endocrine Therapy Is Associated with Improved Survival in Patients with Breast Cancer Brain Metastases in another window
Includes: Supplementary data
Journal Articles

Abstract A5: Characterization of signaling pathways related to resistance of breast cancer cells against irreversible EGFR/HER/ErbB kinase inhibitors

Caroline Bruenner-Kubath, Waheed Shabbir, Victoria Saferding, Renate Wagner, Christian F. Singer, Peter Valent, Walter Berger, Brigitte Marian, Christoph C. Zielinski, Michael Grusch, Thomas W. Grunt
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (7_Supplement): A5.
https://doi.org/10.1158/1078-0432.TCME10-A5
Published: 02 February 2016
View articletitled, Abstract A5: Characterization of signaling pathways related to resistance of breast cancer cells against irreversible EGFR/HER/ErbB kinase inhibitors
Journal Articles

Genome-Wide miRNA Expression Profiling Identifies miR-9-3 and miR-193a as Targets for DNA Methylation in Non–Small Cell Lung Cancers

Gerwin Heller, Marlene Weinzierl, Christian Noll, Valerie Babinsky, Barbara Ziegler, Corinna Altenberger, Christoph Minichsdorfer, György Lang, Balazs Döme, Adelheid End-Pfützenreuter, Britt-Madeleine Arns, Yuliya Grin, Walter Klepetko, Christoph C. Zielinski, Sabine Zöchbauer-Müller
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (6): 1619–1629.
https://doi.org/10.1158/1078-0432.CCR-11-2450
Published: 14 March 2012
View articletitled, Genome-Wide miRNA Expression Profiling Identifies miR-9-3 and miR-193a as Targets for DNA Methylation in Non–Small Cell Lung Cancers
Open the PDF for Genome-Wide miRNA Expression Profiling Identifies miR-9-3 and miR-193a as Targets for DNA Methylation in Non–Small Cell Lung Cancers in another window
Includes: Supplementary data
Journal Articles

Immunization with Mimotopes Prevents Growth of Carcinoembryonic Antigen–Positive Tumors in BALB/c Mice

Kira H. Brämswig, Regina Knittelfelder, Silke Gruber, Eva Untersmayr, Angelika B. Riemer, Krisztina Szalai, Reinhard Horvat, Robert Kammerer, Wolfgang Zimmermann, Christoph C. Zielinski, Otto Scheiner, Erika Jensen-Jarolim
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (21): 6501–6508.
https://doi.org/10.1158/1078-0432.CCR-07-0692
Published: 01 November 2007
View articletitled, Immunization with Mimotopes Prevents Growth of Carcinoembryonic Antigen–Positive Tumors in BALB/c Mice
Open the PDF for Immunization with Mimotopes Prevents Growth of Carcinoembryonic Antigen–Positive Tumors in BALB/c Mice in another window
Journal Articles

Her2 and Progesterone Receptor Status Are Not Predictive of Response to Fulvestrant Treatment

Rupert Bartsch, Catharina Wenzel, Gabriela Altorjai, Ursula Pluschnig, Robert M. Mader, Michael Gnant, Raimund Jakesz, Margaretha Rudas, Christoph C. Zielinski, Guenther G. Steger
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (15): 4435–4439.
https://doi.org/10.1158/1078-0432.CCR-06-3050
Published: 01 August 2007
View articletitled, Her2 and Progesterone Receptor Status Are Not Predictive of Response to Fulvestrant Treatment
Open the PDF for Her2 and Progesterone Receptor Status Are Not Predictive of Response to Fulvestrant Treatment in another window
Journal Articles

Perturbation of the Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand Cascade in Ovarian Cancer: Overexpression of FLIPL and Deregulation of the Functional Receptors DR4 and DR5

Peter Horak, Dietmar Pils, Alexandra Kaider, Alexander Pinter, Katarzyna Elandt, Cornelia Sax, Christoph C. Zielinski, Reinhard Horvat, Robert Zeillinger, Alexander Reinthaller, Michael Krainer
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (24): 8585–8591.
https://doi.org/10.1158/1078-0432.CCR-05-1276
Published: 16 December 2005
View articletitled, Perturbation of the Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand Cascade in Ovarian Cancer: Overexpression of FLIPL and Deregulation of the Functional Receptors DR4 and DR5
Open the PDF for Perturbation of the Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand Cascade in Ovarian Cancer: Overexpression of FLIPL and Deregulation of the Functional Receptors DR4 and DR5 in another window
Journal Articles

Monitoring of Serum Her-2/ neu Predicts Response and Progression-Free Survival to Trastuzumab-Based Treatment in Patients with Metastatic Breast Cancer

Wolfgang J. Köstler, Barbara Schwab, Christian F. Singer, Rainer Neumann, Ernst Rücklinger, Thomas Brodowicz, Sandra Tomek, Monika Niedermayr, Michael Hejna, Günther G. Steger, Michael Krainer, Christoph Wiltschke, Christoph C. Zielinski
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (5): 1618–1624.
https://doi.org/10.1158/1078-0432.CCR-0385-3
Published: 10 March 2004
View articletitled, Monitoring of Serum Her-2/ neu Predicts Response and Progression-Free Survival to Trastuzumab-Based Treatment in Patients with Metastatic Breast Cancer
Open the PDF for Monitoring of Serum Her-2/ neu Predicts Response and Progression-Free Survival to Trastuzumab-Based Treatment in Patients with Metastatic Breast Cancer in another window